{
    "clinical_study": {
        "@rank": "109188", 
        "arm_group": [
            {
                "arm_group_label": "Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "ANT-1401"
            }, 
            {
                "arm_group_label": "Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "ANT-1401"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo Vehicle"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to confirm the effect of ANT-1401 in the treatment of  Lateral\n      Canthal Lines."
        }, 
        "brief_title": "Clinical Trial to Evaluate ANT-1401 in Crow's Feet", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Lateral Canthal Lines", 
            "Crows Feet"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  30 - 60 years of age\n\n          -  mild to moderate Crow's Feet wrinkles (IGA 1-2) at rest\n\n          -  moderate to severe Crow's Feet (IGA 2-3) on contraction\n\n          -  moderate to severe Crow's Feet (SSA 2-3) on contraction\n\n          -  Have adequate vision to assess facial wrinkles in a mirror\n\n        Exclusion Criteria:\n\n          -  botulinum toxin treatment in the prior 6 months\n\n          -  history of periocular surgery, brow lift or related procedures\n\n          -  soft tissue augmentation in the lateral canthal region in the prior 12 months\n\n          -  dermabrasion or laser treatment in the periocular region in the last 6 months\n\n          -  topical prescription-strength retinoids in the prior 3 months\n\n          -  present or history of neuromuscular disease\n\n          -  present or history of \"dry eye\"\n\n          -  systemic aminoglycoside use in the week prior to treatment application"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "109", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01809964", 
            "org_study_id": "ANT-1401-LCL-203"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Dose 1", 
                    "Dose 2"
                ], 
                "intervention_name": "ANT-1401", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "intervention_name": "Vehicle", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "December 10, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35205"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33137"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pinellas Park", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33781"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33401"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metairie", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70006"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Knoxville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37922"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Clinical Trial to Evaluate ANT-1401 in Subjects With Lateral Canthal Lines", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Investigator's Global Assessment Scale", 
            "safety_issue": "No", 
            "time_frame": "Week 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01809964"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Subject Self-Assessment", 
            "safety_issue": "No", 
            "time_frame": "Week 4"
        }, 
        "source": "Anterios Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Anterios Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}